CU23421A3 - DIAZEPINOINDOL DERIVATIVES AS QUINASA INHIBITORS - Google Patents
DIAZEPINOINDOL DERIVATIVES AS QUINASA INHIBITORSInfo
- Publication number
- CU23421A3 CU23421A3 CU20050128A CU20050128A CU23421A3 CU 23421 A3 CU23421 A3 CU 23421A3 CU 20050128 A CU20050128 A CU 20050128A CU 20050128 A CU20050128 A CU 20050128A CU 23421 A3 CU23421 A3 CU 23421A3
- Authority
- CU
- Cuba
- Prior art keywords
- diazepinoindol
- derivatives
- compounds
- quinasa
- inhibitors
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- BSYFXFLGOGQHFU-UHFFFAOYSA-N pyrrolo[2,3-g][1,2]benzodiazepine Chemical class N1=NC=CC=C2C3=NC=CC3=CC=C21 BSYFXFLGOGQHFU-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 101150050673 CHK1 gene Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 102000001253 Protein Kinase Human genes 0.000 abstract 1
- 230000000118 anti-neoplastic effect Effects 0.000 abstract 1
- 229940034982 antineoplastic agent Drugs 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- -1 compounds Salts Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 108060006633 protein kinase Proteins 0.000 abstract 1
- 230000005855 radiation Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Proteína quinasas, tales como CHK-1, que inhiben compuestos tricíclicos de la siguiente fórmula (en la que R2, R3 y R4 son como se han definido en la memoria descriptiva) ESPACIO PARA FÓRMULA composiciones farmaceúticas que contienen cantidades eficaces de dichos compuestos o sus sales son útiles como un único agente o en combinación con un agente anti-neoplásico o radiación terapeútica que tienen un efecto anti-neoplásico para tratar enfermedades o afecciones tales como cánceres.Protein kinases, such as CHK-1, that inhibit tricyclic compounds of the following formula (in which R2, R3 and R4 are as defined in the specification) SPACE FOR FORMULA pharmaceutical compositions containing effective amounts of said compounds or their compounds Salts are useful as a single agent or in combination with an anti-neoplastic agent or therapeutic radiation that have an anti-neoplastic effect to treat diseases or conditions such as cancers.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20050128A CU23421A3 (en) | 2005-06-30 | 2005-06-30 | DIAZEPINOINDOL DERIVATIVES AS QUINASA INHIBITORS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20050128A CU23421A3 (en) | 2005-06-30 | 2005-06-30 | DIAZEPINOINDOL DERIVATIVES AS QUINASA INHIBITORS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU23421A3 true CU23421A3 (en) | 2009-09-08 |
Family
ID=41203573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20050128A CU23421A3 (en) | 2005-06-30 | 2005-06-30 | DIAZEPINOINDOL DERIVATIVES AS QUINASA INHIBITORS |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU23421A3 (en) |
-
2005
- 2005-06-30 CU CU20050128A patent/CU23421A3/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP055911A (en) | INHIBITING TRICYCLIC COMPOUNDS OF PROTEIN KINASE TO IMPROVE THE EFFECTIVENESS OF ANTINEOPLASSIC AGENTS AND RADIATION THERAPY | |
| CR10566A (en) | APPROPRIATE HETEROCICLICAL COMPOUNDS FOR THE TREATMENT OF DISEASES RELATED TO ELEVATED LEVEL OF LIPIDS | |
| CR20110016A (en) | CHEMICAL COMPOUNDS 251 | |
| SV2010003706A (en) | 2,6-DIAMINO-PYRIMIDIN-5-IL-CARBOXAMIDS AS SYK OR JAK KINASAS INHIBITORS | |
| PE20151070A1 (en) | TYROSINE INHIBITORS - BRUTON KINASE | |
| CU20110129A7 (en) | VEGF-R2 PIRIDYLOXI-INDOLES INHIBITORS AND USE OF THE SAME FOR THE TREATMENT OF DISEASES | |
| CU20150163A7 (en) | DERIVATIVES OF 5-HETEROARIL-4-FENIL-4,5-DIHIDROPIRROLO (3,4-c) PIRAZOL-6-ONA ACTIVE AS BET INHIBITORS | |
| EA200901133A1 (en) | DERIVATIVES OF DIANILINOPYRIMIDINE AS KEEIN INHIBITORS WEE1, PHARMACEUTICAL COMPOSITION AND USE | |
| ECSP109935A (en) | PYRIMIDINE MORFOLINE DERIVATIVES USED IN DISEASES RELATED TO MTOR QUINASA AND / OR PI3K | |
| ECSP077324A (en) | BICYCLIC AMIDAS AS INHIBITORS OF CINASA | |
| MX2019012847A (en) | C5-anilinoquinazoline compounds and their use in treating cancer. | |
| EA201490489A1 (en) | PURINUM DERIVATIVES AND THEIR APPLICATION AS A TALL-SIMILAR RECEPTOR MODULATORS 7 | |
| DOP2010000013A (en) | DERIVATIVES OF PIRIMIDINE TRISUSTITUIDA FOR THE TREATMENT OF PROLIFERATIVE DISEASES | |
| ECSP13013068A (en) | HALOGENOALQUIL-1,3-OXAZINAS AS INHIBITORS OF THE BACE1 AND / OR BACE2 | |
| CO6531452A2 (en) | SUBSTITUTED PIPERIDINS THAT INCREASE THE ACTIVITY OF P53 AND ITS USES | |
| EA200901138A1 (en) | DERIVATIVES OF DIANILINOPYRIMIDINE AS KEEIN INHIBITORS WEE1, PHARMACEUTICAL COMPOSITION AND USE | |
| PA8719401A1 (en) | TETRAHYDROPIRIDOTIENOPIRIMIDINA COMPOUNDS AND METHODS FOR USE | |
| PE20150637A1 (en) | PYRROLOTRIAZINONE DERIVATIVES AS PI3K INHIBITORS | |
| ECSP088828A (en) | 4-ANILINOQUINOLINA-3-CARBOXAMIDAS AS INHIBITORS OF THE QUINASE CSF-1R | |
| PA8720801A1 (en) | NEW THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF DEPRESSION | |
| ECSP10010389A (en) | PYRIMIDIL HYDROXYLATED CYCLOPENTANES IN THE FORM OF INHIBITORS OF AKT PROTEINA QUINASA | |
| BR112014010938A2 (en) | 5- (pyridin-2-yl-amino) -pyrazine-2-carbonitrile compounds and their therapeutic use | |
| HN2011000404A (en) | ENFUMAFUNGINA AND COMPOSITION DERIVATIVES UNDERSTANDING THE SAME | |
| GT200700020A (en) | DIBENCILAMINE COMPOUNDS AND DERIVATIVES | |
| CU23421A3 (en) | DIAZEPINOINDOL DERIVATIVES AS QUINASA INHIBITORS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Lapse (for not paying fees) |